A therapeutic mouse anti-CD147 monoclonal antibody (mAb), HAb18, recognizes the residue 39LTCSLNDSATEV50 in domain 1 of CD147 and exerts an anti-metastatic activity in hepatocellular carcinoma through the reduction of MMPs16,17. Here, BSG is linked to hepatocellular carcinoma.